Home › Funds › Cambridge Financial Group, Inc. › COR

Cambridge Financial Group, Inc. position in COR

CENCORA · Health Care

Cambridge Financial Group, Inc. reported holding 36,335 shares of COR (CENCORA) in its Q3 2026 13F filing — a position valued at US$10.9M, representing 4.00% of its reported portfolio and ranking #8 among its reported holdings. Cambridge Financial Group, Inc. has disclosed COR holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)36.34K sh
Reported value held$10.91M
Portfolio Weight4.00%
First reportedQ3 2023
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Cambridge Financial Group, Inc.'s COR position evolved

Cambridge Financial Group, Inc. first disclosed a stake in COR in Q3 2023 at 44,731 shares (US$8.1M). The position peaked in Q4 2025 at 36,425 shares, worth US$12.3M. Across 11 filings, Cambridge Financial Group, Inc. increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 36,335 shares valued at US$10.9M — an increase of 1,073 shares quarter over quarter.. Notable position changes include a 32% trim in Q2 2025 (shares rose 4% over the following quarter), a 34% increase in Q3 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 44.73K $8.05M New
Q4 2023 41.88K $8.60M Reduce
Q1 2024 40.10K $9.74M Reduce
Q4 2024 40.73K $9.15M Add
Q1 2025 40.23K $11.19M Reduce
Q2 2025 27.42K $8.22M Reduce
Q3 2025 36.81K $11.50M Add
Q4 2025 36.42K $12.30M Reduce
Q1 2026 35.39K $11.12M Reduce
Q2 2026 35.26K $9.98M Hold
Q3 2026 36.34K $10.91M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COR and 13F data

COR (CENCORA) is a Health Care company. 36 other funds we track also report a position in COR — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.38B), Carmignac Gestion (US$494.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COR

All COR fund holders →

FAQ

How long has Cambridge Financial Group, Inc. held COR?

Cambridge Financial Group, Inc. has disclosed COR holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is Cambridge Financial Group, Inc.'s current position in COR?

As of Q3 2026, Cambridge Financial Group, Inc. holds 36.34K shares of COR (CENCORA), valued at $10.91M, representing 4.00% of its reported portfolio and ranking #8.

Has Cambridge Financial Group, Inc. been buying or selling COR?

In the latest 13F filing (Q3 2026), Cambridge Financial Group, Inc. increased its position in COR. The position peaked in Q4 2025 at 36.42K shares.

Which other funds hold COR?

Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Carmignac Gestion, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.